ISCP e-Newsletter – December 2024

Editors’ Section

• LinkedIn
• Twitter
• Instagram
• Facebook
• YouTube

---

President’s Section

---

ISCP News

TAKE ISCP Lp(a)AK SURVEY – Lipoprotein(a) Awareness and Knowledge

We are pleased to invite you to participate in the Lp(a)AK survey. This anonymous survey aims to gather valuable insights into healthcare professionals’ understanding of Lp(a), an intriguing yet underexplored cardiovascular risk factor.
Who should participate? All HCP involved in CV care -including physicians, cardiologists, general practitioners, lipid specialists, pharmacists, specialised nurses. We endeavour to gather perspectives from as many countries as possible. To achieve this, we encourage you to share this survey with colleagues and professionals who are well-positioned to contribute. Your insights will help us identify global trends and knowledge gaps, shaping future ISCP educational and research efforts. Complete the survey here

---

29^TH ANNUAL SCIENTIFIC MEETING ISCP 2024

The 29th ISCP Annual Scientific Meeting in São Paulo, Brazil, was an unforgettable gathering, thanks to the remarkable contributions of our esteemed speakers and the engagement of the attendees. Together, we explored groundbreaking advancements in cardiovascular pharmacotherapy, enriched by insightful presentations and dynamic discussions. Watch our highlights video here or browse through a selection of images here.

ISCP 2024 was a celebration of innovation, collaboration, and growth in cardiovascular pharmacotherapy and beyond. Each photo tells a story of insightful presentations, dynamic discussions, and meaningful connections that made this event truly special. Reflecting on the incredible experience, we are filled with gratitude and inspiration!

✨ World-Class Faculty: We had the honour of hosting some of the brightest minds, delivering high-level lectures that sparked curiosity and innovation.
✨ Engaging Discussions: The sessions were alive with thought-provoking questions and shared insights – proof that collaboration fuels progress.
✨ Connections That Matter: From reuniting with old colleagues to welcoming new faces into our community, the networking moments were truly priceless.

This meeting wasn’t just an event; it was a reminder of what makes our field and our organization so special—our shared passion for advancing science together.

---

What’s Next? ISCP 2025!

We’re thrilled to announce that our next Annual Scientific Meeting ISCP 2025 will take place on 25 & 26 September, in Oviedo, Spain! Mark your calendars and get ready for another exceptional opportunity to connect, learn, and collaborate with the global cardiology community. More information on our website soon.

---

2024 GENERAL ASSEMBLY (GA)

This year´s GA was held the past 25^th September, online over Zoom. We revised and reflected on the past year together, our activities and achievements, the lessons learned and everything in between. Our members had the chance to vote on new names joining the Board of Directors, and a new President-Elect for 2025 was named.

We are very excited to welcome A/Prof Doreen Su-Yin Tan from Singapore as the President-Elect for 2025 – and the first ISCP female President! – along with new Board Members Dr Craig Beavers (Governor for USA) and Prof Krzysztof J. Filipiak (Governor for Poland) who will start their roles in January 2025. This marks an exciting chapter for the ISCP as we continue our mission of advancing cardiovascular health globally. 

---

COUNCIL OF GOVERNORS 2024 ANNUAL MEETING

This year’s ISCP CoGs Annual Meeting was held recently, also online. We gathered our ISCP Ambassadors and celebrated their extensive work in the past year, presented the CoG Strategy for 2025 and discussed our plans for the coming year, including a dedicated section on our website to give visibility to their hard work: “Governors Corner”.
Thank you to our Governors for the support and help in spreading the message to every corner of the world.

Want to connect with an ISCP Governor in your region? Meet our Governors here

---

JOINT SESSIONS WITH YOUR LOCAL & REGIONAL ORGANISATIONS

If you or your organisation would like to plan an Official Joint Session with ISCP or wish to request ISCP endorsement for your next meeting, please submit your proposals through our website here. We are keen to collaborate and partner with cardiology related organisations to empower healthcare professionals towards the future of cardiovascular pharmacotherapy.

---

ISCP EDUCATIONAL PROGRAMMES

A to Z of CV Pharmacotherapy Webinars: Recent webinars include Statin’ the source of that pain: Pharmacogenomics as a Preemptive Tool, and Treating Cardiometabolic Syndromes- What’s the best approach?; recorded sessions from our Annual Scientific Meeting ISCP 2024, such as Refractory Angina – A New Approach is Needed for Effective Management by Prof Juan Carlos Kaski, and Pharmacological Interaction with DOACs by A/Prof Doreen Tan. More sessions are being released in the coming weeks so keep visiting our website for new resources.

---

CataLysing ReAl-world CV Pharmacotherapy (CLAP) presentations in 2024 included GLP-1RA in Heart Failure with Preserved Ejection Faction presented by Leo Buckley (USA); Digital Medicine for Hypertension Management presented by Hoao-Ming Cheng, (Taiwan); How to Diagnose Statin-Induced Myopathy presented by Dr Rodrigo Alonso Karlezi (ISCP Governor for Chile). Past webinars and CLAPs are available to view in the On-Demand section of the website.

---

UPCOMING WEBINARS

Anticoagulation Stewardship – Let’s Start a Global Revolution

Join us for a FREE live webinar on Wednesday, January 22nd, 2025, at 7:00 am EST / 12:00 pm GMT, hosted in collaboration with AC Forum.
What to Expect: insights into optimizing anticoagulation therapy; strategies to minimize adverse events and improve patient outcomes; a global perspective on challenges and successes in stewardship programs. Register now and invite your colleagues! On-Demand recording will be exclusive to ISCP Full members.

---

Clinical Application of Real-World Evidence for Atrial Fibrillation (AF) & Venous Thromboembolism (VTE) International Learning Series (CARE-AF/VTE):

ISCP Endorsed and ACForum hosted, free and comprehensive 2-part, 8-week accredited learning series. Running from January 13 – March 3, 2025. Limited spots available. Sign up now!

---

Take Part in ISCP Educational Programmes in 2025: One of the many benefits of being an ISCP Member is to be considered as a keynote speaker for our live webinars, to be part of the panel as an Expert, or to publish articles such as Expert Opinions on novel information that is relevant to the cardiovascular pharmacotherapy community. If you wish to take active part in our educational activities, please send an email to lourdesmarenco@iscpcardio.org with your areas of interests to discuss your involvement further.

---

OTHER INITIATIVES

Announcing an Exciting Global Partnership Between ISCP and Anticoagulation Forum!

We are excited to announce our partnership with ACForum, a non-for-profit organization of multidisciplinary healthcare professionals committed to optimizing antithrombotic patient care, with +30 years of leadership and impact in the field. Together, ISCP and ACForum will continue to grow our global footprint, bringing innovative cardiovascular and anticoagulation management education to healthcare professionals around the world.

This collaboration marks the beginning of several exciting joint initiatives, including educational programmes and events focused on advancing cardiovascular pharmacotherapy and anticoagulation management. Our shared commitment to improving patient outcomes through collaboration, education, and research will drive these efforts forward. These initiatives, built on the foundation of global expertise and evidence-based practices, will offer healthcare professionals wider access to cutting-edge knowledge and resources.

---

Practice-Based Research Study Related to Potassium and Barriers to GDMT in Heart Failure

Through our ISCP Governor in the USA, Dr Craig Beavers, researchers at the University of Kentucky are inviting you to take part in an IRB approved research survey assessing the cardiovascular clinician’s opinion regarding potassium monitoring and use of guideline directed medical therapy in heart failure. If you are a cardiovascular clinician, you are in a position to provide much valuable information concerning this topic. As a member of the cardiovascular community, you are being invited to participate in this study and so we ask your help in completing the survey: Take the survey here

---

News from World Heart Federation (WHF)

Exploring the link between heart disease and air pollution: latest publication in Global Heart Journal, based on the World Heart Report 2024.

European Union takes action for the cardiovascular health of its 440 million people

Roadmap for Secondary Prevention of Cardiovascular Disease: updated roadmap

Report warns cardiovascular disease in Africa is a “time bomb waiting to explode”

---

European Cardiology Review (ECR) – Official ISCP Journal

We are excited to share significant milestones for our official journal, the ECR. In 2023, ECR was included in Clarivate’s Journal Citation Reports list and achieved an impressive Journal Impact Factor of 3.2, ranking 9^th among 69 journals in ESCI’s Cardiac & Cardiovascular Systems category.

As a PubMed-indexed, peer-reviewed, gold open access journal, ECR delivers expertly curated content, including balanced review articles, systematic reviews, expert opinions, and editorials. Under the leadership of Editor-in-Chief Juan Carlos Kaski and Associate Editors Pablo Avanzas and Bianca Rocca, alongside an esteemed editorial board of globally recognized physicians, the journal provides valuable insights into key developments in cardiology. Beyond its articles, the ECR website offers a wealth of resources, including special focus collections, webinars, on-demand videos, and podcasts, ensuring readers stay informed on the latest advancements.

ECR Volume 19 is now available, with all articles free to access and download via the journal’s website. For those interested in contributing, please reach out to Ola Wisniewska at ola.wisniewska@radcliffe-group.com

---

ISCP Book Series: Current Cardiovascular Therapy

The Current Cardiovascular Therapy Series provides both an in-depth view of the science and pharmacology behind these drugs and a practical guide to their usage. Each volume contains practical illustrations and is designed to improve understanding and practical usage of cardiovascular drugs in specific clinical areas.

The Springer series includes 9 books available as e-books or in softcover at a discounted rate for ISCP members. These include: Antiplatelet and Anticoagulation Therapy; Pharmacological Treatment of Acute Coronary Syndromes; Atrial Fibrillation Therapy; Cardiac Drugs in Pregnancy; Pharmacotherapy in Aortic Disease; Pharmacologic Trends of Heart Failure; Pharmacological Treatment of Chronic Stable Angina Pectoris; ACEi and ARBS in Hypertension and Heart Failure; Treatment of Pulmonary Hypertension

---

Upcoming Meetings, Courses and Workshops

---

Social Media

We are actively using the platforms below and all-important updates on new courses and events are announced through those channels so to keep up to date please give us a follow & share our news with your colleagues and peers. FOLLOW US!

• LinkTree https://linktr.ee/iscpcardio
• Instagram https://www.instagram.com/iscpcardio/
• X https://x.com/ISCPcardio
• LinkedIn https://www.linkedin.com/company/international-society-of-cardiovascular-pharmacotherapy/
• Facebook https://www.facebook.com/iscpcardio/
• YouTube https://www.youtube.com/@iscpcardio

---

To unsubscribe to the Newsletters please notify: Lisa Demos at lisa.demos@monash.edu or Lourdes Marenco at lourdesmarenco@iscpcardio.org

---